Cannabis Growth ETF (BUDX) Stock Analysis
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Cannabis Growth ETF (BUDX) trades at $9.97 with AI Score 44/100 (Grade C). Cannabis Growth ETF (BUDX) focuses on global cannabis-related businesses by investing in exchange-traded equity securities. Market cap: $3.55M, Sector: Financial services.
Price as of Aug 21, 2026 · Last analyzed: Mar 18, 2026Analyst Coverage for BUDX: BUDX does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates BUDX against Financial Services peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
BUDX: the 3 scored disciplines are evenly split. Dominant signal: Izzy Englander bullish.
How is this calculated? →Why this analysis is different
- A 9-signal quantitative MoonshotScore built from filings, insider activity, and market data — computed from the numbers, not from opinion.
- An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
- Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.
Cannabis Growth ETF (BUDX) Financial Services Profile
Cannabis Growth ETF (BUDX) provides investors exposure to the global legal cannabis industry through a portfolio of exchange-traded equity securities. Operating as a non-diversified fund, BUDX concentrates its investments in cannabis companies, offering a focused approach to this rapidly evolving sector within the broader asset management landscape.
What Is the Investment Thesis for BUDX?
Cannabis Growth ETF (BUDX) offers a targeted investment vehicle for those seeking exposure to the expanding global cannabis market. The primary value driver is the growth of the legal cannabis industry worldwide, driven by increasing legalization and acceptance. As more countries and regions legalize cannabis for medical or recreational use, the demand for cannabis products is expected to increase, benefiting companies within the BUDX portfolio. The fund's non-diversified structure allows it to capitalize on the potential high growth of specific cannabis companies. However, investors should be aware of the inherent risks associated with the cannabis industry, including regulatory uncertainties and market volatility. The fund's beta of 1.62 indicates higher volatility compared to the overall market.
Based on FMP financials and quantitative analysis
BUDX Key Highlights
BUDX invests at least 80% of its net assets in exchange-traded equity securities of companies engaged in legal cannabis-related businesses.
- The fund may invest in other ETFs that also focus on cannabis companies, providing diversified exposure within the sector.
- BUDX is a non-diversified fund, which allows for concentrated investments in a smaller number of cannabis companies.
- The fund's investment strategy includes the use of derivatives with economic characteristics similar to cannabis company securities.
- BUDX's beta of 1.62 suggests a higher level of volatility compared to the broader market, reflecting the speculative nature of the cannabis industry.
Who Are BUDX's Competitors?
BUDX is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| CNY Market Vectors Chinese Renminbi/USD ETN | $44.25 | +1.96% | $7.63M | 50 |
| LVAFX LSV Global Managed Volatility Fund | $13.28 | -0.38% | $10.6M | 55 |
| WAGSX Wasatch Global Select Fund Investor Class | $12.84 | -0.54% | $12.4M | 51 |
| ASHS Xtrackers Harvest CSI 500 China A-Shares Small Cap ETF | $42.70 | +0.36% | $34.2M | 49 |
| AZTD Aztlan Global Stock Selection Dm SMID ETF | $32.28 | -0.25% | $37.3M | 47 |
| NTSE WisdomTree Emerging Markets Efficient Core Fund | $46.68 | +0.67% | $40.7M | 49 |
| HGGIX Harbor Global Growth Fund - Investor Cl | $24.05 | -0.00% | $40.8M | 50 |
| EFAS Global X - MSCI SuperDividend EAFE ETF | $23.24 | +0.32% | $41.6M | 50 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are BUDX's Key Strengths?
Focused exposure to the high-growth cannabis industry.
- Potential for high returns due to the non-diversified structure.
- Access to a global portfolio of cannabis companies.
- Flexibility to invest in other cannabis ETFs and derivatives.
What Are BUDX's Weaknesses?
High concentration risk due to the non-diversified structure.
- Vulnerability to regulatory changes and market volatility in the cannabis industry.
- Limited diversification compared to broader market ETFs.
- Dependence on the performance of the cannabis sector.
What Could Drive BUDX Stock Higher?
Further legalization of cannabis in key global markets, driving increased demand and investment.
- Product innovation and development of new cannabis-based products, expanding the market and attracting new consumers.
- Consolidation within the cannabis industry through mergers and acquisitions, creating larger and more efficient companies.
What Are the Key Risks for BUDX?
Regulatory setbacks and changes in cannabis laws, hindering market growth and impacting company valuations.
- Market volatility and fluctuations in cannabis stock prices, leading to potential losses for investors.
- Competition from other cannabis ETFs and investment vehicles, impacting market share and returns.
- Negative public perception and social stigma associated with cannabis, limiting market acceptance and growth.
What Are the Growth Opportunities for BUDX?
- Expansion of Legal Cannabis Markets: As more countries and regions legalize cannabis for medical and recreational use, the addressable market for cannabis companies will continue to expand. This growth is expected to drive revenue and earnings growth for companies within the BUDX portfolio. The global legal cannabis market is projected to reach $57 billion by 2027, presenting a significant growth opportunity for BUDX.
- Increased Acceptance and Adoption: As societal attitudes towards cannabis continue to evolve, increased acceptance and adoption of cannabis products are expected. This trend will likely lead to higher demand for cannabis products and services, benefiting companies in the cannabis industry. Education and awareness campaigns are playing a crucial role in shifting public perception and driving adoption.
- Product Innovation and Diversification: Cannabis companies are increasingly focused on product innovation and diversification, developing new and innovative cannabis-based products. This includes edibles, beverages, topicals, and other cannabis-infused products. These new products are attracting a wider range of consumers and driving growth in the cannabis market. BUDX can benefit from investing in companies that are at the forefront of product innovation.
- Mergers and Acquisitions: The cannabis industry is undergoing consolidation, with larger companies acquiring smaller players to gain market share and expand their operations. This trend is creating opportunities for BUDX to invest in companies that are potential acquisition targets or that are actively involved in mergers and acquisitions. Consolidation can lead to increased efficiency and profitability for cannabis companies.
- Development of Cannabis-Based Pharmaceuticals: The potential for cannabis-based pharmaceuticals is a significant growth driver for the industry. Research and development efforts are underway to develop cannabis-based treatments for various medical conditions. Successful development and commercialization of these pharmaceuticals could generate substantial revenue for cannabis companies and boost the value of BUDX's holdings. Clinical trials and regulatory approvals are key milestones in this area.
What Are BUDX's Competitive Advantages?
- First-mover advantage in offering a dedicated ETF focused on the global cannabis industry.
- Expertise in selecting and managing investments in cannabis companies.
- Established relationships with key players in the cannabis industry.
- Brand recognition and reputation as a leading cannabis ETF.
What Does BUDX Do?
Cannabis Growth ETF (BUDX) is designed to provide investors with exposure to the global legal cannabis industry. The fund achieves this by investing primarily in exchange-traded equity securities of companies engaged in legal cannabis-related businesses. These businesses span various aspects of the cannabis industry, including cultivation, processing, distribution, and retail. BUDX operates under the principle of investing at least 80% of its net assets, plus any borrowings for investment purposes, in these cannabis companies. BUDX may also invest in other exchange-traded funds (ETFs) that have a policy to invest at least 80% of their assets in securities of cannabis companies. This allows the fund to gain broader exposure to the sector through diversified investment vehicles. Additionally, BUDX may utilize derivatives that have economic characteristics similar to the securities of cannabis companies, providing further flexibility in its investment strategy. It is important to note that BUDX is a non-diversified fund. This means that it can invest a larger percentage of its assets in a smaller number of issuers compared to a diversified fund. While this strategy can potentially lead to higher returns if the cannabis sector performs well, it also carries a higher level of risk due to the concentration of investments.
What Products and Services Does BUDX Offer?
- Invests in exchange-traded equity securities of companies engaged in legal cannabis-related businesses.
- Focuses on companies involved in cultivation, processing, distribution, and retail of cannabis.
- May invest in other ETFs that have a policy to invest in securities of cannabis companies.
- Utilizes derivatives with economic characteristics similar to cannabis company securities.
- Provides investors with exposure to the global legal cannabis industry.
- Operates as a non-diversified fund, concentrating investments in the cannabis sector.
How Does BUDX Make Money?
- Generates returns through the appreciation of the value of its investments in cannabis companies.
- Collects management fees from investors based on the fund's assets under management (AUM).
- May generate income from dividends or interest payments received from its investments.
- Trades securities within the portfolio to optimize returns and manage risk.
What Industry Does BUDX Operate In?
The asset management industry is evolving with the emergence of specialized ETFs like BUDX, targeting niche sectors such as the cannabis industry. The global cannabis market is experiencing rapid growth, driven by increasing legalization and changing consumer attitudes. This growth presents both opportunities and challenges for asset managers. BUDX operates in a competitive landscape that includes other ETFs and investment vehicles focused on cannabis. The fund's success depends on its ability to effectively select and manage investments in cannabis companies, navigating regulatory complexities and market volatility.
Who Are BUDX's Key Customers?
- Individual investors seeking exposure to the cannabis industry.
- Institutional investors looking to diversify their portfolios with cannabis-related assets.
- Financial advisors seeking investment options for their clients interested in the cannabis sector.
- High-net-worth individuals seeking growth opportunities in emerging markets.
Cannabis Growth ETF (BUDX) Valuation Context
Valued at $3.55M, BUDX is classified as a micro-cap stock. Relative to its peer group, BUDX's quantitative score of 44/100 is roughly in line with the peer average of 50/100.
Key Financial Metrics
Return on equity for Cannabis Growth ETF stands at 0.0%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 0.0%, showing how much profit it generates from its asset base. BUDX trades at a trailing price-to-earnings ratio of 0.00, below the Financial Services sector average of ~18x. Its free cash flow yield is 0.0%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.00 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is 0.0%, the inverse of the P/E and a quick read on earnings relative to price.
BUDX Financials
Bull Case vs Bear Case
Bull Case
- Focused exposure to the high-growth cannabis industry.
- Potential for high returns due to the non-diversified structure.
- Access to a global portfolio of cannabis companies.
- Flexibility to invest in other cannabis ETFs and derivatives.
Bear Case
- High concentration risk due to the non-diversified structure.
- Vulnerability to regulatory changes and market volatility in the cannabis industry.
- Limited diversification compared to broader market ETFs.
- Dependence on the performance of the cannabis sector.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · August 2026
BUDX Latest News
No recent news available for BUDX.
BUDX Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for BUDX.
Price Targets
Wall Street price target analysis for BUDX.
BUDX MoonshotScore
What does this score mean?
The MoonshotScore rates BUDX 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.
What Investors Ask About Cannabis Growth ETF (BUDX) — Financial Services
What does the AI Score mean for BUDX?
BUDX holds an AI Score of 44/100 (Grade: C). This is an educational research signal, not a buy or sell recommendation. Cannabis Growth ETF (BUDX) focuses on global cannabis-related businesses by investing in exchange-traded equity securities. The fund operates as a non-diversified entity, concentrating its …
What does Cannabis Growth ETF do?
Cannabis Growth ETF (BUDX) is an exchange-traded fund that focuses on providing investors with exposure to the global legal cannabis industry. The fund invests primarily in exchange-traded equity securities of companies engaged in legal cannabis-related businesses. This includes companies involved in cultivation, processing, distribution, and retail of cannabis.
What are the main risks for BUDX?
The main risks for BUDX include regulatory uncertainty, market volatility, and competition. The cannabis industry is subject to evolving regulations, which can impact the operations and profitability of cannabis companies. Market volatility can lead to fluctuations in cannabis stock prices, potentially resulting in losses for investors.
What are the key factors to evaluate for BUDX?
Cannabis Growth ETF (BUDX) holds an AI score of 44/100 (low). Cannabis Growth ETF (BUDX) offers a targeted investment vehicle for those seeking exposure to the expanding global cannabis market. Not financial advice.
How frequently does BUDX data refresh on this page?
BUDX's price was last updated on Aug 21, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven BUDX's recent stock price performance?
Cannabis Growth ETF (BUDX) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Focused exposure to the high-growth cannabis industry. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider BUDX overvalued or undervalued right now?
Cannabis Growth ETF (BUDX) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
How do I research BUDX before investing?
Before investing in Cannabis Growth ETF (BUDX), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Why might investors consider adding BUDX to a portfolio?
Key strength of Cannabis Growth ETF (BUDX): Focused exposure to the high-growth cannabis industry. Weigh rewards against risks and diversify. Not financial advice.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- The cannabis industry is subject to rapid changes in regulations and market conditions.
- The performance of BUDX is dependent on the performance of the cannabis sector.
- The fund's non-diversified structure increases concentration risk.